Bone Marrow Transplantation News

Patients with VEXAS syndrome who were blood transfusion dependent or had a variant of the valine gene exhibited a threefold increased risk for mortality, according to data presented at ACR Convergence 2021.

Three individuals have been elected to American Society of Hematology’s executive committee.

New guidelines for sickle cell disease issued by ASH and published in Blood Advances aim to inform practitioners and patients on use of hematopoietic stem cell transplantation in clinical practice.

The FDA granted orphan drug designation to posoleucel for the treatment of virus-associated hemorrhagic cystitis, according to the agent’s manufacturer.

September is Blood Cancer Awareness Month.

The FDA approved ruxolitinib for treatment of certain patients with chronic graft-versus-host disease.

The FDA granted fast track designation to VOR33, an engineered allogeneic stem cell therapy for the treatment of patients with acute myeloid leukemia who are at high risk for relapse.

Accounting for the benign rs2814778-CC genotype when considering a bone marrow biopsy could avoid unnecessary procedures, particularly in African American patients, according to findings published in JAMA Internal Medicine.

For years, hematopoietic stem cell transplantation physicians have viewed a matched unrelated donor as the gold standard when a matched related donor is unavailable.

National Comprehensive Cancer Network updated its guidance on COVID-19 vaccination for patients with cancer following FDA authorization of a third mRNA vaccine dose for certain immunocompromised individuals.